EUVIMEDEUVIMED entdecken
Open Access

Hybrid chalcone-pyrazoline derivatives: synthesis and in silico evaluation for anticancer potential

Purabi Saha iD, Azra Yasmin iD, Ritesh Jha iD, Aarti Passi iD, Vikramdeep Monga iD, Shammy Jindal iD, Kamya Goyal iD

Future Medicinal Chemistry · 2025

DOI: 10.1080/17568919.2025.2561464 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Future Medicinal Chemistry, 2025. Verfasst von Purabi Saha und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, ISF College of Pharmacy, Moga, India. Hauptthemen laut MEDLINE: Antineoplastic Agents, Pyrazoles, Protein Kinase Inhibitors, Chalcone. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AIM: This study aimed to design, synthesize, and evaluate a hybrid chalcone-pyrazoline derivatives as potential anticancer agents targeting B-Raf kinase in lung cancer. MATERIAL & METHODS: Chalcone-pyrazoline derivatives (PY1-PY10) were synthesized via Claisen-Schmidt condensation followed by cyclization, characterized using FT-IR, NMR, and LC-MS. In vitro cytotoxic activity was assessed against A549 human lung cancer cells using the MTT assay. Molecular docking studies were performed with B-Raf kinase (PDB ID: 2FB8) using Schrödinger software. ADME properties were predicted using SwissADME. RESULT: Compound PY7 exhibited the most potent cytotoxicity (IC₅₀ = 6.45 µM) and the highest docking score (-8.89 kcal/mol), showing strong binding interactions with GLN530 in B-Raf kinase. Structure Activity Relationship analysis revealed that electron-withdrawing para-nitro substituents enhanced potency, while electron-donating groups generally reduced activity. ADME profiling confirmed all compounds complied with Lipinski's Rule of Five, had high gastrointestinal absorption, and displayed favorable drug-likeness. CONCLUSION: The findings identify PY7 as a promising lead candidate with potent anticancer activity, strong B-Raf binding affinity, and favorable pharmacokinetics. This work supports chalcone-pyrazole scaffolds as viable templates for the development of novel targeted lung cancer therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsPyrazolesProtein Kinase InhibitorsChalconeChalconesHumansMolecular Docking SimulationStructure-Activity RelationshipProto-Oncogene Proteins B-rafDrug Screening Assays, AntitumorA549 CellsCell ProliferationCell Line, TumorMolecular Structure

Stichwörter der Autor:innen

B-Raf kinaseChalconeanticancerin vitrolung cancermolecular dockingpyrazoline

Substanzen

Antineoplastic AgentsPyrazolesProto-Oncogene Proteins B-rafProtein Kinase InhibitorsChalconeChalcones

Autor:innen und Institutionen

  • Department of Pharmaceutical Chemistry, ISF College of Pharmacy, Moga, India.
  • Department of Pharmaceutical Analysis, ISF College of Pharmacy, Moga, India.
  • Department of Pharmaceutical Sciences and Natural Products, School of Health Sciences, Central University of Punjab, Bathinda, India.
  • Department of Pharmaceutics, ISF College of Pharmacy and Research, Moga, India.
  • Department of Pharmaceutical Chemistry and Analysis, ISF College of Pharmacy, Moga, India.

ORCID-Profile: Purabi Saha, Azra Yasmin, Ritesh Jha, Aarti Passi, Vikramdeep Monga, Shammy Jindal, Kamya Goyal

Zitieren

APA

Saha, P., Yasmin, A., Jha, R., Passi, A., Monga, V., Jindal, S., & Goyal, K. (2025). Hybrid chalcone-pyrazoline derivatives: synthesis and in silico evaluation for anticancer potential. Future Medicinal Chemistry. https://doi.org/10.1080/17568919.2025.2561464

Vancouver

Saha P, Yasmin A, Jha R, Passi A, Monga V, Jindal S, et al. Hybrid chalcone-pyrazoline derivatives: synthesis and in silico evaluation for anticancer potential. Future Medicinal Chemistry. 2025. doi:10.1080/17568919.2025.2561464

BibTeX
@article{Saha2025,
  author = {Saha, Purabi and Yasmin, Azra and Jha, Ritesh and Passi, Aarti and Monga, Vikramdeep and Jindal, Shammy and Goyal, Kamya},
  title = {Hybrid chalcone-pyrazoline derivatives: synthesis and in silico evaluation for anticancer potential},
  journal = {Future Medicinal Chemistry},
  year = {2025},
  doi = {10.1080/17568919.2025.2561464}
}
Kostenlos starten →